-
Je něco špatně v tomto záznamu ?
Complete Genome and Plasmids Sequences of a Clinical Proteus mirabilis Isolate Producing Plasmid Mediated NDM-1 from Italy
I. Bitar, V. Mattioni Marchetti, A. Mercato, E. Nucleo, A. Anesi, S. Bracco, V. Rognoni, J. Hrabak, R. Migliavacca,
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
Grantová podpora
17-29239A
Czech Health Research Council
Q39
Charles University Research Fund PROGRES
LO1503
National Sustainability Program I (NPU I)
CZ.02.1.01/0.0/0.0/16_019/0000787
Ministry of Education Youth and Sports of the Czech Republic
NV17-29239A
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
NLK
Directory of Open Access Journals
od 2013
PubMed Central
od 2013
Europe PubMed Central
od 2013
ProQuest Central
od 2013-01-01
Open Access Digital Library
od 2013-01-01
Open Access Digital Library
od 2013-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2013
- Publikační typ
- časopisecké články MeSH
Background: The spread of carbapenemase genes, such as blaNDM-1, in Proteus mirabilis poses a public health threat. The aim of the study was to characterize the genome and plasmids sequences of an NDM-1-positive strain (IBCRE14), which was isolated in 2019 from a catheterized patient hospitalized in Italy. Methods: Whole genome sequencing (WGS) of IBCRE14 was performed on extracted genomic DNA using Sequel I platform. Genome assembly was performed using "Microbial Assembly". Genomic analysis was conducted by uploading the contigs to ResFinder and PlasmidFinder databases from the Center for Genomic Epidemiology. Results: IBCRE14 had a genome size of 4,018,329 bp and harboured genes coding for resistance to aminoglycosides (aadA1), phenicol (cat), tetracycline (tetJ), and trimethoprim (dfrA1). A large plasmid (pIB_NDM_1) harboured antibiotic resistance genes against sulphonamide (sul1), trimethoprim (dfrA14), tetracycline (tetB), rifampicin (arr-2), aminoglycosides (aadA1, aph3-VI), and beta-lactams (blaOXA-10, blaNDM-1). Furthermore, a small plasmid (pIB_COL3M) harboured a qnrD1 gene coding for quinolone resistance. Conclusion: The ability to conjugate and the presence of a composite antibiotic resistance island suggests that pIB_NDM_1 could both acquire more resistance genes and easily disseminate. To our knowledge, this is the first report on an untypable plasmid harbouring blaNDM-1 in P. mirabilis, in Italy.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20005093
- 003
- CZ-PrNML
- 005
- 20210310105306.0
- 007
- ta
- 008
- 200511s2020 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/microorganisms8030339 $2 doi
- 035 __
- $a (PubMed)32121207
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Bitar, Ibrahim $u Department of Microbiology, Faculty of Medicine, and University Hospital in Pilsen, Charles University, 32300 Pilsen, Czech Republic. Biomedical Center, Faculty of Medicine in Pilsen, Charles University, 32300 Pilsen, Czech Republic.
- 245 10
- $a Complete Genome and Plasmids Sequences of a Clinical Proteus mirabilis Isolate Producing Plasmid Mediated NDM-1 from Italy / $c I. Bitar, V. Mattioni Marchetti, A. Mercato, E. Nucleo, A. Anesi, S. Bracco, V. Rognoni, J. Hrabak, R. Migliavacca,
- 520 9_
- $a Background: The spread of carbapenemase genes, such as blaNDM-1, in Proteus mirabilis poses a public health threat. The aim of the study was to characterize the genome and plasmids sequences of an NDM-1-positive strain (IBCRE14), which was isolated in 2019 from a catheterized patient hospitalized in Italy. Methods: Whole genome sequencing (WGS) of IBCRE14 was performed on extracted genomic DNA using Sequel I platform. Genome assembly was performed using "Microbial Assembly". Genomic analysis was conducted by uploading the contigs to ResFinder and PlasmidFinder databases from the Center for Genomic Epidemiology. Results: IBCRE14 had a genome size of 4,018,329 bp and harboured genes coding for resistance to aminoglycosides (aadA1), phenicol (cat), tetracycline (tetJ), and trimethoprim (dfrA1). A large plasmid (pIB_NDM_1) harboured antibiotic resistance genes against sulphonamide (sul1), trimethoprim (dfrA14), tetracycline (tetB), rifampicin (arr-2), aminoglycosides (aadA1, aph3-VI), and beta-lactams (blaOXA-10, blaNDM-1). Furthermore, a small plasmid (pIB_COL3M) harboured a qnrD1 gene coding for quinolone resistance. Conclusion: The ability to conjugate and the presence of a composite antibiotic resistance island suggests that pIB_NDM_1 could both acquire more resistance genes and easily disseminate. To our knowledge, this is the first report on an untypable plasmid harbouring blaNDM-1 in P. mirabilis, in Italy.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Mattioni Marchetti, Vittoria $u Dipartimento di Scienze Clinico-Chirurgiche, Diagnostiche e Pediatriche, Università degli Studi di Pavia, 27100 Pavia, Italy.
- 700 1_
- $a Mercato, Alessandra $u Dipartimento di Scienze Clinico-Chirurgiche, Diagnostiche e Pediatriche, Università degli Studi di Pavia, 27100 Pavia, Italy.
- 700 1_
- $a Nucleo, Elisabetta $u Dipartimento di Scienze Clinico-Chirurgiche, Diagnostiche e Pediatriche, Università degli Studi di Pavia, 27100 Pavia, Italy.
- 700 1_
- $a Anesi, Adriano $u Laboratorio di Microbiologia, Azienda Socio Sanitaria Territoriale di Lodi, 26900 Lodi, Italy.
- 700 1_
- $a Bracco, Silvia $u Laboratorio di Microbiologia, Azienda Socio Sanitaria Territoriale di Lodi, 26900 Lodi, Italy.
- 700 1_
- $a Rognoni, Vanina $u Laboratorio di Microbiologia, Azienda Socio Sanitaria Territoriale di Lodi, 26900 Lodi, Italy.
- 700 1_
- $a Hrabak, Jaroslav $u Department of Microbiology, Faculty of Medicine, and University Hospital in Pilsen, Charles University, 32300 Pilsen, Czech Republic. Biomedical Center, Faculty of Medicine in Pilsen, Charles University, 32300 Pilsen, Czech Republic.
- 700 1_
- $a Migliavacca, Roberta $u Dipartimento di Scienze Clinico-Chirurgiche, Diagnostiche e Pediatriche, Università degli Studi di Pavia, 27100 Pavia, Italy.
- 773 0_
- $w MED00198767 $t Microorganisms $x 2076-2607 $g Roč. 8, č. 3 (2020)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32121207 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200511 $b ABA008
- 991 __
- $a 20210310105303 $b ABA008
- 999 __
- $a ind $b bmc $g 1524023 $s 1095148
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 8 $c 3 $e 20200228 $i 2076-2607 $m Microorganisms $n Microorganisms $x MED00198767
- GRA __
- $a 17-29239A $p Czech Health Research Council
- GRA __
- $a Q39 $p Charles University Research Fund PROGRES
- GRA __
- $a LO1503 $p National Sustainability Program I (NPU I)
- GRA __
- $a CZ.02.1.01/0.0/0.0/16_019/0000787 $p Ministry of Education Youth and Sports of the Czech Republic
- GRA __
- $a NV17-29239A $p MZ0
- LZP __
- $a Pubmed-20200511